Ovata Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$12.2M |
| 2 |
Rio Tinto
RIO
|
+$5.57M |
| 3 |
Alight
ALIT
|
+$2.96M |
| 4 |
Talos Energy
TALO
|
+$2.92M |
| 5 |
Transocean
RIG
|
+$2.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Exchange Traded Funds Simplify Bitcoin Strategy ETF
MAXI
|
+$19.2M |
| 2 |
TSMC
TSM
|
+$13.7M |
| 3 |
Kenvue
KVUE
|
+$4.75M |
| 4 |
ONC
BeOne Medicines Ltd
ONC
|
+$4.05M |
| 5 |
NetEase
NTES
|
+$3.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 27.14% |
| 2 | Financials | 20.84% |
| 3 | Energy | 7.91% |
| 4 | Technology | 7.57% |
| 5 | Consumer Staples | 0% |
Similar funds
Ovata Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Ovata Capital Management held 20 positions worth $53.7M, down 33% from $79.7M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Ovata Capital Management withdrew a net $24.4M in Q4 2023, closing 8 positions and reducing 2 holdings. Its most notable exit was Simplify Exchange Traded Funds Simplify Bitcoin Strategy ETF, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Materials at 27% of assets, up from 10% a quarter earlier, followed by Financials and Energy.
Against the trend, Ovata Capital Management opened a new position in HDFC Bank worth $11.2M.
- Ovata Capital Management's largest Q4 2023 buy was HDFC Bank: 402,950 shares worth $11.2M.
- Ovata Capital Management's biggest Q4 2023 reduction was BHP, cutting an estimated $82.5K.
- Ovata Capital Management fully exited Simplify Exchange Traded Funds Simplify Bitcoin Strategy ETF in Q4 2023, selling an estimated $19.2M.
- Ovata Capital Management's ten largest holdings make up 99% of its $53.7M portfolio in Q4 2023.
- Ovata Capital Management opened 7 new positions and closed 8 in Q4 2023.
- Ovata Capital Management's portfolio value fell 33% quarter-over-quarter to $53.7M.
Based on Ovata Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.